Publisher: Adis International
ISSN: 1173-8324
Source: Inpharma, Vol.1, Iss.1507, 2005-01, pp. : 6-6
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Similar drug persistency patterns for rivastigmine, donepezil in AD
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 486, 2005-01 ,pp. :
Rivastigmine slows AD and cuts costs
Inpharma, Vol. 1, Iss. 1242, 2000-01 ,pp. :
Rivastigmine reduces need for neuropsychotherapeutics in AD
Inpharma, Vol. 1, Iss. 1504, 2005-01 ,pp. :
Rivastigmine slows AD and cuts costs
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 267, 2000-01 ,pp. :